Hiraki et al. (29) indicated that no viable intrahepatic recurrence, no liver cirrhosis, Child–Pugh A class, and serum AFP level lower than 10 ng/ml were associated with better survival for patients with pulmonary metastases from HCC undergoing percutaneous RFA. The gene discussed is AFP; the disease is cirrhosis of liver.